BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 15217557)

  • 1. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
    Kang EM; Tisdale JF
    Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotoxicity of retroviral integration in hematopoietic cells.
    Nienhuis AW; Dunbar CE; Sorrentino BP
    Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modification of hematopoietic cells using retroviral and lentiviral vectors: safety considerations for vector design and delivery into target cells.
    Dropulic B
    Curr Hematol Rep; 2005 Jul; 4(4):300-4. PubMed ID: 16009045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy resumes.
    Novak K
    Nat Rev Cancer; 2002 Nov; 2(11):813. PubMed ID: 12442759
    [No Abstract]   [Full Text] [Related]  

  • 6. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
    Kaiser J
    Science; 2005 Jun; 308(5729):1735-6. PubMed ID: 15961648
    [No Abstract]   [Full Text] [Related]  

  • 7. Is retroviral gene marking too dangerous to use?
    Brenner MK; Heslop HE
    Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
    [No Abstract]   [Full Text] [Related]  

  • 8. Retroviral vectors: new applications for an old tool.
    Barquinero J; Eixarch H; PĂ©rez-Melgosa M
    Gene Ther; 2004 Oct; 11 Suppl 1():S3-9. PubMed ID: 15454951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking into the safety of AAV vectors.
    Kay MA; Nakai H
    Nature; 2003 Jul; 424(6946):251. PubMed ID: 12867952
    [No Abstract]   [Full Text] [Related]  

  • 10. Occurrence of leukaemia following gene therapy of X-linked SCID.
    Kohn DB; Sadelain M; Glorioso JC
    Nat Rev Cancer; 2003 Jul; 3(7):477-88. PubMed ID: 12835668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy in retrovirally modified haematopoietic cell therapy.
    Li Z; Modlich U; Baum C
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):493-503. PubMed ID: 15498719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral vectors for gene therapy of AIDS and cancer.
    Chang LJ; He J
    Curr Opin Mol Ther; 2001 Oct; 3(5):468-75. PubMed ID: 11699891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine. Gene therapy--new challenges ahead.
    Williams DA; Baum C
    Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell gene transfer: insights into integration and hematopoiesis from primate genetic marking studies.
    Dunbar CE
    Ann N Y Acad Sci; 2005 Jun; 1044():178-82. PubMed ID: 15958711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy. Second child in French trial is found to have leukemia.
    Marshall E
    Science; 2003 Jan; 299(5605):320. PubMed ID: 12531981
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene therapy. What to do when clear success comes with an unclear risk?
    Marshall E
    Science; 2002 Oct; 298(5593):510-1. PubMed ID: 12386304
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress towards hematopoietic stem cell gene therapy.
    Kurre P; Kiem HP
    Curr Opin Mol Ther; 2000 Aug; 2(4):400-11. PubMed ID: 11249770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.
    Bester AC; Schwartz M; Schmidt M; Garrigue A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Ben-Porat N; Von Kalle C; Fischer A; Kerem B
    Gene Ther; 2006 Jul; 13(13):1057-9. PubMed ID: 16511518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic stem cell gene therapy: progress toward therapeutic targets.
    Vollweiler JL; Zielske SP; Reese JS; Gerson SL
    Bone Marrow Transplant; 2003 Jul; 32(1):1-7. PubMed ID: 12815471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.